What it sells
Mycelium-based paving material.
Business model breakdown
Buyer: who owns the budget?
UnverifiedMunicipal and private developers and landscape/urban design firms specifying paving (inferred).
Trigger: what makes them buy now?
Need for fossil-free paving that cuts CO2 and manufacturing energy.
Workflow: what inputs become what output?
Mycelium-cultivated visiBINDER binds agricultural waste and aggregates into visiPAVER pavers; visiBIT asphalt-alternative binder is in development and seeking test partners.
Economics: what it saves and how it charges
UnverifiedProduct sales of pavers and binder licensing/production via partners (inferred); still in development and pilot stage.
Distribution: how it reaches customers
UnverifiedPartnering with concrete maker IBF to scale production.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-07-13 | — | €3.34M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.